21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Transdermal penetration system and treatment for cellulite
#24302Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
#24303Combination of voriconazole and an antifungal CYP2C19 inhibitor
#24304Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
#24305Combination of gamma-aminobutyric acid modulators and 5-HT1B receptor antagonists
#24306Fused ring 4-oxopyrimidine derivative
#24307Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
#24308Medicinal composition containing an HMG-CoA reductase inhibitor
#24309Use of phospholipids in peritoneal dialysis
#24310Compositions of estrogen-cyclodextrin complexes
#24311Chondroprotective/restorative compositions and methods of use thereof
#24312Treatment of shock using adrenomedullin binding protein-1
#24313Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
#24314Anti-dermatophytic preparation and use thereof
#24315Chinese traditional medicines for psoriasis
#24316Health food and a pharmaceutical preparation containing a native plant of Loranthaceae family of the tropical region or an extract thereof
#24317Composition for treating AIDS and associated conditions
#24318Compositions and methods for treatment of diabetes
#24319Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
#24320Composition and method for modulating hydrogen ion physiology
#24321Composite powder and cosmetic containing the same
#24322Synergistic antibacterial formulation and to a method of making the same
#24323Aerosol delivery of curcumin
#24324Confectionary products including agent for controlling weight
#24325Ocular drug delivery
#24326Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
#24327Cancer therapy
#24328Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
#24329Inactivated probiotic bacteria and methods of use thereof
#24330Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
#24331Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
#24332Inhalable aerosol medicament for the treatment or prevention of pain
#24333Formulations and methods for treating rhinosinusitis
#24334Resorbable polymeric device for localized drug delivery
#24335Compositions and methods for glycogen synthesis
#24336Anti-inflammatory nitro- and thia- fatty acids
#24337Anti-inflammatory nitro- and thia-fatty acids
#24338Anti-inflammatory nitro-and thia-fatty acids
#24339Vitamin combination for providing protection during the chemotherapy and/or radio-therapy of malignant tumours
#24340Method and compositions for treatment of painful disorders
#24341Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
#24342Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
#24343Monoamine oxidase (MAO) inhibitors and uses thereof
#24344Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
#24345Combination of glivec (STI571) with a cyclin-dependent kinase inhibitor, especially flavopiridol, in the treatment of cancer
#24346Aryl-substituted heterocycles, process for their preparation and their use as medicaments
#24347Heterocyclic antiviral compounds
#243487-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
#24349Synergistic anit-cancer compounds
#24350Combination therapy for the treatment of estrogen-sensitive disease
#24351Method for treatment of reactive arthritis or bursitis
#24352Use of tyrosine kinase inhibitors for treating autoimmune diseases
#24353Method for inhibiting bone resorption with an alendronate and vitamin d formulation
#24354Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#24355Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
#24356Uridine administration stimulates membrane production
#24357Composition and method for use in cartilage affecting conditions
#24358Antiviral oligonucleotides
#24359Anthelmintic oral homogeneous veterinary pastes
#24360Peptides as NS3-serine protease inhibitors of hepatitis C virus
#24361Use of osteopontin for the treatment and/or prevention of neurologic diseases
#24362Formulations useful in the treatment of male and female impotence
#24363Vaccinium species compositions
#24364Anti-Allergy composition and related method
#24365Method and herbal composition for treatment of diabetes
#24366Cellular depolarization and regulation of matrix metalloproteinases
#24367Long acting compositions comprising zidovudine and lamivudine
#24368Pharmaceutical formulation comprising melatonin
#24369Medical implants and fibrosis-inducing agents
#24370Stable loratadine spill resistant formulation
#24371Methods for enhancing wound healing
#24372Saponins as anticancer agent
#24373Compositions and methods for treating hyperimmune response in the eye
#24374Treatment of autoimmune diseases, including AIDS
#24375Wound healing compositions and methods using tropoelastin and lysyl oxidase
#24376Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
#24377Anti-neoplastic viral agents
#24378Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
#24379Combination therapies using vitamin B12 and interferon for treatment of viral proliferative and inflammatory disesases
#24380Functionalized colloidal metal compositions and methods
#24381Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
#24382Use of taurine for treating alopecia
#24383Natural sunscreen compositions and processes for producing the same
#24384Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases
#24385Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD
#24386Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
#24387Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
#24388Production of Δ 9 tetrahydrocannabinol
#24389Method and composition for combination treatment of neurodegenerative disorders
#24390Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α (PPAR)
#24391Use of EPA and DHA in secondary prevention
#24392Combination chemotherapy for helminth infections
#24393Modulators of the glucocorticoid receptor and method
#24394Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
#24395Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists
#24396Pharmaceutical compositions comprising abacavir and lamivudine
#24397Enhancing the efficacy of tubercular drugs
#24398Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
#24399Combinations useful for the treatment of neuronal disorders
#24400Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
#24401Combination of CRF antagonists and 5-HT1B receptor antagonists
#24402Compositions for treating CNS disorders
#24403Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#24404Compositions containing piperacillin and tazobactam
#24405Therapeutic combinations and methods including IRM compounds
#24406Menstrual cycle control and improvement of conception rates in females
#24407Methods and reagents for the treatment of multiple sclerosis
#24408In vivo use of glutathione S-transferase activated nitric oxide donors
#24409Use of phosphono derivatives as anti-malarials
#24410Carrageenan based antimicrobial compositions
#24411Organ arrest, protection and preservation
#24412Therapeutic combinations
#24413Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination
#24414Compositions and methods for the regulation of homocysteine levels within the body
#24415Methods for the treatment of cancer
#24416Method and composition for the treatment of cancer
#24417Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
#24418Acidic insulin preparations having improved stability
#24419Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety
#24420Extracts of blueberries with anti-oxidant and anti-cancer properties
#24421Antiproliferative colchicine compositions and uses thereof
#24422Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia
#24423Composition for treating a dermatological inflammatory response and method of preparation thereof
#24424Pharmaceutical Antidiabetic Composition
#24425Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
#24426Ude of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix
#24427Stabilized formulations
#24428Growth promoting pharmaceutical implant
#24429Medical implants and fibrosis-inducing agents
#24430Medical implants and fibrosis-inducing agents
#24431Increasing tumor oxygen content by administration of stressed cells
#24432PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer
#24433Anti-CD40 antibodies capable of blocking B-cell activation
#24434Method of treating hemolytic disease
#24435Composition and methods afor diagnosis and treatment of cardiovascular disorders
#24436Methods related to immunostimulatory nucleic acid-induced interferon
#24437Method of treating Crohn's Disease using sargramostim
#24438Antibacterial compositions and method of using same
#24439Pharmaceutical composition with combined active agents and methods for using the same
#24440Biocidal agents and veterinary methods
#24441Compositions and dosage forms for enhanced absorption
#24442Pain management system
#24443Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation
#24444Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
#24445Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#24446Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
#24447Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
#24448Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
#24449Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
#24450Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors
#24451Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
#24452Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
#24453Melatonin combination therapy for improving sleep quality
#24454Use of sulfoalkyl ether cyclodextrin as a preservative
#24455Pharmaceutical composition for ophthalmological and rhinological application
#24456Method for normalizing insulin levels
#24457Combination of a cdk inhibitor and 5-fu for the tratment of cancer
#24458Orally administered small peptides synergize statin activity
#24459Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors
#24460Growth factor homolog zvegf4
#24461Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
#24462Neuroprotective complex for treatment of cerebral ischemia and injury
#24463Synthetic urine and method of manufacturing same
#24464Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections
#24465Therapeutic agent of skin diseases
#24466Cancer treatment using natural plant products or essential oils or components from some pistacia species
#24467Methods and formulations for treating glaucoma
#24468Compositions and methods for reducing cholesterol
#24469Caralluma extract products and processes for making the same
#24470Herbal composition for treatment of digestive and urinary disorders
#24471Tablet composition containing Kampo medicinal extract and its manufacturing process
#24472Nutritional supplement to treat macular degeneration
#24473Injectable compositions for the controlled delivery of pharmacologically active compound
#24474Administration of levodopa and carbidopa
#24475Compositions and dosage forms for enhanced absorption of iron
#24476Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
#24477Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
#24478Rosiglitazone and metformin formulations
#24479Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
#24480Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof
#24481Methods for recovering peptides from stress protein-peptide complexes
#24482Prevention and treatment of amyloidogenic disease
#24483Combination of anti-EP-CAM antibody with a chemotherapeutic agent
#24484Extracorporeal photopheresis in combination with anti-TNF treatment
#24485Combination therapy for B cell disorders
#24486Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
#24487Treatment with agonists of toll-like receptors
#24488Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
#24489Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
#24490Anti-adhesion balloons
#24491Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
#24492Cancer treatment
#24493Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases
#24494Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolferative diseases
#24495Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
#24496Management of postoperative pain
#24497Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
#24498Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
#24499Use of substituted pyrimido[5,4-D]pyrimidines for the treatment of respiratory diseases
#24500Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
#24501Organic compound
#24502Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
#24503Compositions and methods of treatment for inflammatory diseases
#24504Combination therapy for treatment of FIV infection
#24505Non-nucleotide compositions and method for inhibiting platelet aggregation
#24506In-vivo energy depleting strategies for killing drug-resistant cancer cells
#245076-11 bicyclic ketolide derivatives
#24508Method of treatment of otitis externa
#24509Wound treatment composition and process of manufacture
#24510Treatment of DNA viral infections
#24511Pharmaceutical compositions and treatment methods - 8
#24512Remedies for sex hormone-dependent disease
#24513Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers
#24514GLP-1 pharmaceutical compositions
#24515Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase
#24516Method for inhibiting the formation of seromas using factor XIII
#24517Growth factor therapy mobilization of stem cells into the peripheral blood
#24518Type II diabetes
#24519Method and composition for relieving symptoms of arthritis and gout using fruit of miracles
#24520Food improving blood flow
#24521Antipyrotic and method of manufacturing the same
#24522Methods for treating joint inflammation
#24523Personal decontaminant
#24524Composition and method for treatment of acne
#24525Preparation of Chinese herbal composite recipe used in environmental sanitation
#24526Treatment and diagnosis of conditions associated with elevated arginase activity
#24527Method for producing polymeric sol of calcium phosphate compound and method for coating the same on a metal implant
#24528Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
#24529Antioxidative preparations
#24530Controlled release formulations of opioid and nonopioid analgesics
#24531Compositions and dosage forms for enhanced absorption of metformin
#24532HIV-encoded chemoattractant
#24533Rehydrating personal lubricant and method of use
#24534Methods and products related to metabolic interactions in disease
#24535Immunomodulatory combinations
#24536Combinations for the treatment of proliferative diseases
#24537Compositions and methods for modulating muscle cell and tissue contractility
#24538Treating abdominal pain due to pancreatitis with seaprose
#24539Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#24540Methods of organ regeneration using -expressing pluripotent cells
#24541Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine red blood cells
#24542Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
#24543Medical implants and fibrosis-inducing agents
#24544Sympathetic nerve-stimulating fragrant compositions
#24545Methods and compositions for the treatment of skin changes associated with aging and environmental damage
#24546Agents for bleaching teeth
#24547Hybrid cells
#24548Stabilized ascorbic acid compositions and methods therefor
#24549Methods of treating an inflammatory-related disease
#24550Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and alpha-agonist
#24551(2-carboxamido)(3-Amino) thiophene compounds
#24552Pressurised metered dose inhalers containing solutions of beta-2 agonists
#24553Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
#24554New compounds
#24555Pharmaceutical compositions based on a scopineester and nicotinamide derivatives
#24556Treatment of statin side effects using uridine derivatives
#24557Methods of treating acute inflammation in animals with p38 map kinase inhibitors
#24558Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
#24559Methods for inhibiting sterol absorption
#24560Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
#24561Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
#24562Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof
#24563Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
#24564Chaperone-based therapy for Niemann-Pick disease
#24565Natural cyclodextrin complexes
#24566Inhibition of a novel calcium injury current that forms in nuerons during injury prevents neuronal cell death
#24567Targeted drug delivery using EphA2 or EphA4 binding moieties
#24568Antiviral oligonucleotides targeting viral families
#24569Aminoglycoside treatment for lysosomal storage diseases
#24570Therapeutical conversion
#24571Compound B as an angiogenic agent in combination with human growth factors
#24572Composition for stimulating de novo bone induction
#24573Method for screening FGFR-4 agonists
#24574Herbal bidi/beedi
#24575Composition and method for smoke detoxification
#24576Peppermint isopropyl alcohol
#24577All natural flavor enhancers for green tea beverages and dental hygiene product
#24578Methods and compositions for promoting axon regeneration and cell replacement therapy
#24579Composition for and method of treatment for skin ailments
#24580Medium chain peroxycarboxylic acid compositions
#24581Method for treating irritable bowel syndrome
#24582Method of increasing testosterone and related steroid concentrations in women
#24583Phaseolamin compositions and methods for using the same
#24584Mouse prostate stem cell antigen and uses thereof
#24585Treatment of diabetic retinopathy
#24586Methods of inducing T-cell non-responsiveness with anti-gp39 24-31 antibodies
#24587Methods and materials for the inhibition of transplant rejection
#24588Protonic formulation
#24589Vaccine immunotherapy for immune suppressed patients
#24590Agents for enhancing the immune response
#24591Migration of hematopoietic stem cells and progenitor cells to the liver
#24592Skin treatment composition
#24593Ceramide emulsions
#24594CREAM FOR TREATMENT OF SKIN INJURED BY THE SUN
#24595Use of antibacterial component extracted from cacao mass for inhibiting the growth of periodontal bacteria
#24596Formoterol superfine formulation
#24597Abuse-proofed dosage system
#24598Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain condition
#24599Lipoxin compounds and their use in treating cell proliferative disorders
#24600Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium